These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 21551161

  • 1. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, Follath F, Goulder M, Willenheimer R, CIBIS-III investigators.
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [Abstract] [Full Text] [Related]

  • 2. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, Ponikowski P, Skene A, van de Ven L, Verkenne P, Lechat P, CIBIS III Investigators.
    Circulation; 2005 Oct 18; 112(16):2426-35. PubMed ID: 16143696
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL, van Veldhuisen DJ, Goulder M, Zilahi Z, Meyer WR, Willenheimer R.
    Int J Cardiol; 2010 Sep 24; 144(1):59-63. PubMed ID: 19481278
    [Abstract] [Full Text] [Related]

  • 6. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.
    Cardiology; 2007 Sep 24; 108(1):28-34. PubMed ID: 16960445
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
    Dobre D, van Veldhuisen DJ, Goulder MA, Krum H, Willenheimer R.
    Cardiovasc Drugs Ther; 2008 Oct 24; 22(5):399-405. PubMed ID: 18528751
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ, CARMEN investigators and co-ordinators.
    Eur J Heart Fail; 2004 Jun 24; 6(4):467-75. PubMed ID: 15182773
    [Abstract] [Full Text] [Related]

  • 13. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep 29; 147(39):10. PubMed ID: 16245769
    [No Abstract] [Full Text] [Related]

  • 14. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009 Sep 29; 20(1):78. PubMed ID: 19382368
    [No Abstract] [Full Text] [Related]

  • 15. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study.
    Pitt B, Latini R, Maggioni AP, Solomon SD, Smith BA, Wright M, Prescott MF, McMurray JJ.
    Eur J Heart Fail; 2011 Jul 29; 13(7):755-64. PubMed ID: 21467028
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 29; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 17. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997 Oct 29; 11(2):138-42. PubMed ID: 9107560
    [Abstract] [Full Text] [Related]

  • 18. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M, Podbregar M, Kovacic D, Rozman J, von Haehling S.
    Respir Med; 2011 Oct 29; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [Abstract] [Full Text] [Related]

  • 19. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P, Roudaut R, Herrero G, Dallocchio M.
    J Cardiovasc Pharmacol; 1990 Oct 29; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators.
    N Engl J Med; 2001 Dec 06; 345(23):1667-75. PubMed ID: 11759645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.